118 related articles for article (PubMed ID: 27770021)
1. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.
Woodward DF; Wang JW; Ni M; Bauer A; Martos JL; Carling RW; Poloso NJ
FASEB J; 2017 Jan; 31(1):368-375. PubMed ID: 27770021
[TBL] [Abstract][Full Text] [Related]
2. Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.
Wang JW; Woodward DF; Martos JL; Cornell CL; Carling RW; Kingsley PJ; Marnett LJ
FASEB J; 2016 Jan; 30(1):394-404. PubMed ID: 26420849
[TBL] [Abstract][Full Text] [Related]
3. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
Woodward DF; Krauss AH; Wang JW; Protzman CE; Nieves AL; Liang Y; Donde Y; Burk RM; Landsverk K; Struble C
Br J Pharmacol; 2007 Feb; 150(3):342-52. PubMed ID: 17179945
[TBL] [Abstract][Full Text] [Related]
4. A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes.
Woodward DF; Wang JW; Spada CS; Carling RW; Martos JL; Pettit S; Kangasmetsa J; Waterbury LD; Lawrence M; Hu W; Poloso NJ
ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1199-1210. PubMed ID: 33344897
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled prostanoid receptors and the kidney.
Breyer MD; Breyer RM
Annu Rev Physiol; 2001; 63():579-605. PubMed ID: 11181968
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
Wang XS; Lau HY
Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
9. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
Chen J; Woodward DF
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
[TBL] [Abstract][Full Text] [Related]
10. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.
Chan CL; Jones RL; Lau HY
Br J Pharmacol; 2000 Feb; 129(3):589-97. PubMed ID: 10711359
[TBL] [Abstract][Full Text] [Related]
11. Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments.
Woodward DF; Wenthur SL; Rudebush TL; Fan S; Toris CB
J Ocul Pharmacol Ther; 2016 Nov; 32(9):606-622. PubMed ID: 27763812
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin receptors: their role in regulating renal function.
Breyer MD; Breyer RM
Curr Opin Nephrol Hypertens; 2000 Jan; 9(1):23-9. PubMed ID: 10654821
[TBL] [Abstract][Full Text] [Related]
13. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
[TBL] [Abstract][Full Text] [Related]
14. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
[TBL] [Abstract][Full Text] [Related]
16. The effects of prostaglandin analogues on intracellular Ca2+ in ciliary arteries of wild-type and prostanoid receptor-deficient mice.
Abe S; Watabe H; Takaseki S; Aihara M; Yoshitomi T
J Ocul Pharmacol Ther; 2013 Feb; 29(1):55-60. PubMed ID: 23046436
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation.
Murase A; Okumura T; Sakakibara A; Tonai-Kachi H; Nakao K; Takada J
Eur J Pharmacol; 2008 Feb; 580(1-2):116-21. PubMed ID: 18031725
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
[TBL] [Abstract][Full Text] [Related]
19. Role of prostanoid production and receptors in the regulation of retinal endogenous amino acid neurotransmitters by 8-isoprostaglandin E2, ex vivo.
Zhao M; Destache CJ; Ohia SE; Opere CA
Neurochem Res; 2009 Dec; 34(12):2170-80. PubMed ID: 19513831
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones.
Jenkins DW; Feniuk W; Humphrey PP
Br J Pharmacol; 2001 Nov; 134(6):1296-302. PubMed ID: 11704650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
